Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer
Open Access
- 1 May 2011
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 286 (21), 19127-19137
- https://doi.org/10.1074/jbc.m110.216887
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- MicroRNA-21: From Cancer to Cardiovascular DiseaseCurrent Drug Targets, 2010
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDFCancer Research, 2010
- MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expressionJournal of Experimental & Clinical Cancer Research, 2010
- Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN statusLaboratory Investigation, 2010
- Antisense Inhibition of microRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic AdenocarcinomaPancreas, 2009
- MicroRNA-21 targets tumor suppressor genes in invasion and metastasisCell Research, 2008
- Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient SurvivalClinical Cancer Research, 2008
- Interleukin-6–dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancerBlood, 2007
- MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)Journal of Biological Chemistry, 2007
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004